---
schema_version: "secwatch.filing_event.v1"
accession: "0001764013-22-000007"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2022-01-07T23:59:59+00:00"
generated_at: "2026-06-27T19:56:18.643390+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Immunovant to present corporate overview at J.P. Morgan Healthcare Conference on Jan 13, 2022

## Summary
- CEO Pete Salzmann to present on Thursday, January 13, 2022 at 9:45am ET.
- Webcast available via investor relations section of Immunovant's website.
- No new financial or clinical data announced in the press release.
- Presentation is part of the 40th Annual J.P. Morgan Healthcare Conference (Jan 10-13).

## SEC filing metadata
- accession: 0001764013-22-000007
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2022-01-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000176401322000007/0001764013-22-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000176401322000007/imvt-20220107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764013-22-000007
- JSON: https://secwatch.observer/filing/0001764013-22-000007.json
- Plain text: https://secwatch.observer/filing/0001764013-22-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.